AMETEK Inc has a consensus price target of $174.93 based on the ratings of 16 analysts. The high is $205 issued by Keybanc on February 27, 2024. The low is $122 issued by B of A Securities on July 11, 2022. The 3 most-recent analyst ratings were released by Truist Securities, Oppenheimer, and Baird on July 2, 2024, May 22, 2024, and May 6, 2024, respectively. With an average price target of $191.67 between Truist Securities, Oppenheimer, and Baird, there's an implied 11.52% upside for AMETEK Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/02/2024 | Buy Now | 18.69% | Truist Securities | Jamie Cook | $210 → $204 | Maintains | Buy | Get Alert |
05/22/2024 | Buy Now | 16.37% | Oppenheimer | Christopher Glynn | → $200 | Upgrade | Perform → Outperform | Get Alert |
05/06/2024 | Buy Now | -0.51% | Baird | Richard Eastman | $173 → $171 | Maintains | Neutral | Get Alert |
03/14/2024 | Buy Now | 22.19% | Truist Securities | Jamie Cook | → $210 | Initiates | → Buy | Get Alert |
02/27/2024 | Buy Now | 19.28% | Keybanc | Steve Barger | $182 → $205 | Maintains | Overweight | Get Alert |
02/07/2024 | Buy Now | 9.39% | RBC Capital | Deane Dray | $192 → $188 | Maintains | Outperform | Get Alert |
02/07/2024 | Buy Now | 5.89% | Keybanc | Steve Barger | $176 → $182 | Maintains | Overweight | Get Alert |
11/27/2023 | Buy Now | -6.91% | TD Cowen | Joseph Giordano | $165 → $160 | Downgrade | Outperform → Market Perform | Get Alert |
11/01/2023 | Buy Now | 8.22% | RBC Capital | Deane Dray | $183 → $186 | Maintains | Outperform | Get Alert |
09/21/2023 | Buy Now | 5.89% | RBC Capital | Deane Dray | → $182 | Reiterates | Outperform → Outperform | Get Alert |
08/07/2023 | Buy Now | 13.46% | Seaport Global | Scott Graham | → $195 | Initiates | → Buy | Get Alert |
08/02/2023 | Buy Now | 5.89% | RBC Capital | Deane Dray | $174 → $182 | Maintains | Outperform | Get Alert |
08/02/2023 | Buy Now | 1.24% | Morgan Stanley | Joshua Pokrzywinski | $162 → $174 | Maintains | Overweight | Get Alert |
08/02/2023 | Buy Now | -3.42% | Mizuho | Brett Linzey | $161 → $166 | Maintains | Buy | Get Alert |
08/02/2023 | Buy Now | 7.64% | Wells Fargo | Allison Poliniak Cusic | $180 → $185 | Maintains | Overweight | Get Alert |
08/02/2023 | Buy Now | 2.4% | Keybanc | Steve Barger | $165 → $176 | Maintains | Overweight | Get Alert |
07/12/2023 | Buy Now | -5.74% | Morgan Stanley | Joshua Pokrzywinski | $159 → $162 | Maintains | Overweight | Get Alert |
06/08/2023 | Buy Now | 4.73% | DA Davidson | Matt Summerville | $177 → $180 | Maintains | Buy | Get Alert |
05/04/2023 | Buy Now | -7.49% | Morgan Stanley | Joshua Pokrzywinski | $155 → $159 | Maintains | Overweight | Get Alert |
05/03/2023 | Buy Now | -4% | RBC Capital | Deane Dray | → $165 | Reiterates | → Outperform | Get Alert |
05/03/2023 | Buy Now | -6.32% | Mizuho | Brett Linzey | $153 → $161 | Maintains | Buy | Get Alert |
02/23/2023 | Buy Now | — | Wolfe Research | Nigel Coe | — | Downgrade | Outperform → Peer Perform | Get Alert |
02/03/2023 | Buy Now | -9.82% | Morgan Stanley | Joshua Pokrzywinski | $152 → $155 | Maintains | Overweight | Get Alert |
01/13/2023 | Buy Now | -10.98% | Mizuho | Brett Linzey | $145 → $153 | Maintains | Buy | Get Alert |
01/06/2023 | Buy Now | -11.56% | Morgan Stanley | Joshua Pokrzywinski | $144 → $152 | Maintains | Overweight | Get Alert |
11/21/2022 | Buy Now | -4% | Keybanc | Steve Barger | $145 → $165 | Maintains | Overweight | Get Alert |
11/02/2022 | Buy Now | -20.87% | RBC Capital | Deane Dray | $135 → $136 | Maintains | Outperform | Get Alert |
11/02/2022 | Buy Now | -15.63% | Mizuho | Brett Linzey | $140 → $145 | Maintains | Buy | Get Alert |
11/02/2022 | Buy Now | -16.22% | Morgan Stanley | Joshua Pokrzywinski | $137 → $144 | Maintains | Overweight | Get Alert |
10/24/2022 | Buy Now | -4% | Wells Fargo | Allison Poliniak Cusic | $180 → $165 | Maintains | Overweight | Get Alert |
10/12/2022 | Buy Now | -20.29% | Morgan Stanley | Joshua Pokrzywinski | $145 → $137 | Maintains | Overweight | Get Alert |
08/03/2022 | Buy Now | -18.54% | Mizuho | Brett Linzey | $135 → $140 | Maintains | Buy | Get Alert |
08/03/2022 | Buy Now | -15.63% | Morgan Stanley | Joshua Pokrzywinski | $135 → $145 | Maintains | Overweight | Get Alert |
08/03/2022 | Buy Now | -21.45% | RBC Capital | Deane Dray | — | Maintains | Outperform | Get Alert |
07/19/2022 | Buy Now | -9.82% | Loop Capital | Scott Graham | $170 → $155 | Maintains | Buy | Get Alert |
07/18/2022 | Buy Now | -21.45% | Mizuho | Brett Linzey | $159 → $135 | Maintains | Buy | Get Alert |
07/11/2022 | Buy Now | -29.02% | B of A Securities | Andrew Obin | → $122 | Downgrade | Buy → Neutral | Get Alert |
05/31/2022 | Buy Now | -21.45% | Morgan Stanley | Joshua Pokrzywinski | $144 → $135 | Maintains | Overweight | Get Alert |
05/04/2022 | Buy Now | -16.22% | Morgan Stanley | Joshua Pokrzywinski | $158 → $144 | Maintains | Overweight | Get Alert |
05/04/2022 | Buy Now | -13.89% | RBC Capital | Deane Dray | $146 → $148 | Maintains | Outperform | Get Alert |
05/04/2022 | Buy Now | -15.63% | Keybanc | Steve Barger | $155 → $145 | Maintains | Overweight | Get Alert |
03/18/2022 | Buy Now | -9.82% | Keybanc | Steve Barger | $160 → $155 | Maintains | Overweight | Get Alert |
01/14/2022 | Buy Now | -8.07% | Morgan Stanley | Joshua Pokrzywinski | $159 → $158 | Maintains | Overweight | Get Alert |
12/17/2021 | Buy Now | -7.49% | Mizuho | Brett Linzey | — | Initiates | → Buy | Get Alert |
12/14/2021 | Buy Now | -3.42% | Wolfe Research | Nigel Coe | — | Upgrade | Peer Perform → Outperform | Get Alert |
11/03/2021 | Buy Now | -7.49% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
11/03/2021 | Buy Now | -4.58% | RBC Capital | Deane Dray | — | Maintains | Outperform | Get Alert |
10/07/2021 | Buy Now | -10.4% | Morgan Stanley | Joshua Pokrzywinski | — | Maintains | Overweight | Get Alert |
08/04/2021 | Buy Now | -9.23% | Morgan Stanley | Joshua Pokrzywinski | — | Maintains | Overweight | Get Alert |
08/04/2021 | Buy Now | -6.91% | Rosenblatt | Scott Graham | — | Maintains | Buy | Get Alert |
08/04/2021 | Buy Now | -6.91% | Keybanc | Steve Barger | — | Maintains | Overweight | Get Alert |
The latest price target for AMETEK (NYSE:AME) was reported by Truist Securities on July 2, 2024. The analyst firm set a price target for $204.00 expecting AME to rise to within 12 months (a possible 18.69% upside). 16 analyst firms have reported ratings in the last year.
The latest analyst rating for AMETEK (NYSE:AME) was provided by Truist Securities, and AMETEK maintained their buy rating.
The last upgrade for AMETEK Inc happened on May 22, 2024 when Oppenheimer raised their price target to $200. Oppenheimer previously had a perform for AMETEK Inc.
The last downgrade for AMETEK Inc happened on November 27, 2023 when TD Cowen changed their price target from $165 to $160 for AMETEK Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AMETEK, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AMETEK was filed on July 2, 2024 so you should expect the next rating to be made available sometime around July 2, 2025.
While ratings are subjective and will change, the latest AMETEK (AME) rating was a maintained with a price target of $210.00 to $204.00. The current price AMETEK (AME) is trading at is $171.87, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.